HarborLabs CEO Nick Yuran distinguishes cybersecurity from cyberscience, and explains why understanding the shared scientific disciplines of regulators and security professionals are important in achieving positive regulatory outcomes.
As more medical devices leverage phones and other consumer devices, are they introducing more risk to patients? We’ll go inside a conceptual hack and explore the impact of the crossover between unregulated third-party devices and smart medical devices.
The common vulnerability scoring system is a valuable tool, but how strictly should medical organizations rely on it? When assessing medical and healthcare technology, does it bring enough information, or does it fall short?
HarborLabs’ CEO, Nick Yuran, was recently interviewed about misconceptions and concerns around the FDA’s new policies on wireless management of infusion pumps. Here are his thoughts regarding the interview and the overall risks involved.